Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy

Chemotherapy remains the standard treatment for triple‐negative breast cancer (TNBC); however, chemoresistance compromises its efficacy. The RNA‐binding protein Hu antigen R (HuR) could be a potential therapeutic target to enhance the chemotherapy efficacy. HuR is known to mainly stabilize its targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Lanjing, Zhang, Qi, Zhong, Cuncong, He, Lily, Zhang, Yuxia, Armaly, Ahlam M., Aubé, Jeffrey, Welch, Danny R., Xu, Liang, Wu, Xiaoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552894/
https://www.ncbi.nlm.nih.gov/pubmed/37357618
http://dx.doi.org/10.1002/1878-0261.13478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552894/
https://www.ncbi.nlm.nih.gov/pubmed/37357618
http://dx.doi.org/10.1002/1878-0261.13478

Ejemplares similares